Radiation Oncology Advances

Forfatter
Spar {0}
Spar {0} som ARK-VENN
{0} til nettpris
med Klikk&Hent
Format/språk
   Klikk og hent - få varen innen 2 timer*
   Alltid bytterett - Norges beste. Bytt uten kvittering.
* Gjelder varer på lager i butikk

Kort om boken

from combining radiation with a molecular targeted agent - namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of …

Oppdag mer

Velg tagger...

    Om Radiation Oncology Advances

    from combining radiation with a molecular targeted agent - namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap. 7 as a potential target in combination with fractionated radiotherap y for head and neck squamous cell carcinoma (HNSCC). A flurry of agents are under de velopment for targeting EGFR and in March 2006, the US Food and Drugs Administration approved cetuximab combined with radiation as a primary treatment option for patients with loco- regionally advanced HNSCC in whom chemoradiation therapy is deemed not to be an option. While blocking the EGF pathway during fractionated radiotherapy may seem an obvious strategy [5], the rationale for combining antiangiogenic and antivascular targeting agents with radiation may be less intuitive. However, recent research shows that there are several reasons why this could result in a therapeutic gain in practice. Chapter 8 is a review of this rapidly expanding field by Citrin and Camphausen. Targeted agents combined with radiation may offer new opportunities in the treatment of central nervous system malignancies, a tumor type where the outlook remains poor despite some recent progress [6]. Current attempts to overcome rad- tion resistance in these tumors on the basis of an improved understanding of their molecular biology are the topic of Chap. 9 by Chakravarti and Palanichamy.

    Kundevurderinger

    Totalvurdering: 

    Gi din vurdering: 
    Totalvurdering: 

    Detaljer

    Format
    E-Bok
    Kopisperre
    Teknisk DRM
    Filformat
    PDF
    Utgivelsesår
    2007
    Forlag
    Springer US
    Språk
    Engelsk
    ISBN
    9780387367446

    Anbefalt

    Nettleseren din er utdatert

    Mye funksjonalitet på ark.no støttes ikke lenger i Internet Explorer. Vennligst bruk en nyere nettleser.